Upcoming events

TAVI (Transcatheter aortic valve implantation)

Here you will find all the latest content on transcatheter aortic valve implantations (TAVI) published on this website. Results are listed in chronological order.

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Find out more…

Filtered By
TAVI

392 results

LIVE case: TF TAVI in intermediate risk patient with S3 valve

From GulfPCR-GIM 2016

Consult this LIVE case on TF TAVI in intermediate risk patient with S3 valve, if you want to learn more about TAVI with the SAPIEN family as an established and efficient procedure.A 75-year-old female with an aortic stenosis:•    No predilatation•    TEE, pressure and angio assessment

Khaled Al Merri

Operator

Khaled Al Merri

Operator

Darar Al Khdair

LIVE case: TF TAVI with Sapien 3

From PCR Tokyo Valves 2016

Watch this LIVE case if you want to learn more about TF TAVI with Sapien 3.A frailty 81-year-old female with aortic stenosis and severe restriction syndrome:•    Transfemoral approach•    Cerebral protection•    Sapien 3 implanted without predilatation

Nicolas Dumonteil

Operator

Nicolas Dumonteil
Dr. Didier Tchétché

Operator

Didier Tchétché

TAVI for severe symptomatic AS in presence of mechanical mitral valve replacement

04 Jan 2017

A 74 year old Chinese female with significant past history of severe mitral regurgitation secondary to mitral valve prolapse treated mechanical mitral valve replacement in 1997 and atrial fibrillation was admitted for breathlessness and heart failure.

Author

Kay-Woon Ho

LIVE case: making TAVI simple in lower risk patients

From PCR London Valves 2016

Consult this LIVE case on making TAVI simple in lower risk patients from St. Thomas' Hospital - London, United Kingdom.Clinical caseA 80-year-old female with severe aortic stenosis:Transfemoral approachWith pre-dilatationTEE assessment

Jane Hancock

Operator

Jane Hancock
Dr Bernard Prendergast

Operator

Bernard Prendergast
Dr. Simon Redwood

Operator

Simon Redwood

LIVE case: TAVI using new adjunctive technologies

From PCR London Valves 2016

Consult this LIVE case on TAVI using new adjunctive technologies from the Clinique Pasteur - Toulouse, France.Clinical CaseA 85-year-old female with aortic stenosis:Trans femoral accessCerebral protection deviceWithout pre dilatation

Nicolas Dumonteil

Operator

Nicolas Dumonteil
Dr. Didier Tchétché

Operator

Didier Tchétché

LIVE case: minimally invasive TAVI

From EuroPCR 2016

Watch this LIVE case if you want to learn more about minimally invasive TF TAVI.A 84-year-old male with severe aortic stenosis and LM disease:PCI of LM has been done 3 weeks agoIntermediate risk patientLV wire as a temporary P.M.

Operator

Hakim Benamer
Thierry Lefèvre

Operator

Thierry Lefevre

Acute and long-term stroke prevention in TAVI patients

The rate of stroke, an earlier observed clinical complication in TAVI, has receded, but we still need to remain vigilant. While definitive studies are still ongoing, we join C. K. Naber, A. Linke and C. Tamburino to discuss the complexity of understanding brain accidents during and after TAVI.What is the frequency or importance of stroke or cerebral vascular incidents during TAVI, especially in the number of emboli going to the brain? How do we assess patients and lesions, and what is the role of cerebral protection devices? Does arrhythmia play a part in mid- and long-term incidents? Learn more of our evolving understanding of TAVI and the brain in this fascinating conversation…

TAVI, achieving the balance between simplification and safety

TAVI is now considered a safe and standard treatment for AS in severely ill patients, but today the challenge is to streamline the procedure from before it begins to when the patient is discharged.Learn more as P. MacCarthy and C. Tamburino join M. Gilard to discuss the various stages of TAVI: “Before”, patient selection and the goal of matching the patient to the best prostheses. “During”, eliminating unnecessary secondary clinical elements and using conscious sedation. “After”, training and informing staff and family to ensure quick mobilisation of the patient. Can we accomplish this? What’s at risk? Learn more.

LIVE case: a simplified TF TAVI

From EuroPCR 2016

Watch this LIVE case on a simplified TF TAVI.A 81-year-old male with severe aortic stenosis:Degenerative mitral valve diseaseNo predilatationAngio assessment

Prof. Stefan Windecker

Operator

Stephan Windecker

Operator

Stefan Stortecky

TAVI in low-risk patients, what is required for TAVI to become the new gold standard?

TAVI…a new standard in lower-risk patients? With the publication of the PARTNER 2 results the world of interventional cardiology is buzzing with excitement.Join P. MacCarthy, O. Wendler and R. S. Von Bardeleben to see where we stand today... To begin with, how do we define “lower-risk” patients? Do we really have enough data to “replace” surgery in these cases? What are our criteria for “safety”, especially concerning long-term survival? What about newer-generation technologies including valves and closure devices? And is there a trade-off between eliminating a paravalvular leak and a pacemaker? What are the next steps? Join the debate today!